Vital Farms, Inc. (NASDAQ:VITL – Get Free Report) insider Hoven Reena Chauhan Van acquired 2,242 shares of the business’s stock in a transaction dated Tuesday, May 19th. The shares were bought at an average price of $8.92 per share, with a total value of $19,998.64. Following the transaction, the insider directly owned 25,827 shares in the company, valued at approximately $230,376.84. The trade was a 9.51% increase in their position. The purchase was disclosed in a legal filing with the SEC, which is available through this hyperlink.
Vital Farms Price Performance
Shares of NASDAQ:VITL opened at $10.13 on Friday. Vital Farms, Inc. has a one year low of $7.95 and a one year high of $53.13. The stock has a fifty day moving average of $12.41 and a 200-day moving average of $23.44. The company has a market capitalization of $434.07 million, a PE ratio of 9.74 and a beta of 1.20. The company has a debt-to-equity ratio of 0.01, a quick ratio of 1.00 and a current ratio of 1.77.
Vital Farms (NASDAQ:VITL – Get Free Report) last announced its quarterly earnings data on Thursday, May 7th. The company reported ($0.03) EPS for the quarter, missing analysts’ consensus estimates of $0.09 by ($0.12). Vital Farms had a net margin of 6.10% and a return on equity of 14.47%. The company had revenue of $187.16 million for the quarter, compared to analyst estimates of $182.40 million. During the same quarter last year, the company posted $0.37 EPS. Vital Farms’s revenue was up 15.4% on a year-over-year basis. As a group, equities analysts anticipate that Vital Farms, Inc. will post -0.45 EPS for the current fiscal year.
More Vital Farms News
- Positive Sentiment: Director Glenda Flanagan and insider Hoven Reena Chauhan Van both bought shares recently, signaling some internal confidence in Vital Farms after the post-earnings selloff. Article Title
- Neutral Sentiment: The company’s latest quarter missed earnings expectations but beat on revenue, leaving investors focused on mixed fundamentals after the May 7 report. Article Title
- Negative Sentiment: Multiple law firms, including Berger Montague, Faruqi & Faruqi, Schall, Pomerantz, Rosen, and Robbins, are urging investors to join or inquire about a securities class action tied to alleged misconduct during the May 2025 to February 2026 period. Article Title
- Negative Sentiment: The lawsuits allege Vital Farms executives concealed shipment disruptions and misled investors about business prospects, adding legal uncertainty ahead of the May 26 lead-plaintiff deadline. Article Title
Institutional Trading of Vital Farms
Several hedge funds and other institutional investors have recently modified their holdings of the company. Van Berkom & Associates Inc. purchased a new position in Vital Farms in the fourth quarter valued at about $3,442,000. Divisadero Street Capital Management LP grew its stake in Vital Farms by 131.7% in the third quarter. Divisadero Street Capital Management LP now owns 993,338 shares of the company’s stock valued at $40,876,000 after purchasing an additional 564,711 shares in the last quarter. Principal Financial Group Inc. grew its stake in Vital Farms by 23.1% in the third quarter. Principal Financial Group Inc. now owns 1,377,681 shares of the company’s stock valued at $56,692,000 after purchasing an additional 258,092 shares in the last quarter. Hussman Strategic Advisors Inc. purchased a new position in Vital Farms in the third quarter valued at about $1,728,000. Finally, Citigroup Inc. grew its stake in Vital Farms by 554.1% in the third quarter. Citigroup Inc. now owns 95,258 shares of the company’s stock valued at $3,920,000 after purchasing an additional 80,694 shares in the last quarter. 98.59% of the stock is currently owned by hedge funds and other institutional investors.
Wall Street Analysts Forecast Growth
VITL has been the subject of a number of research analyst reports. Weiss Ratings lowered Vital Farms from a “hold (c)” rating to a “hold (c-)” rating in a report on Wednesday, April 29th. Morgan Stanley set a $10.00 target price on Vital Farms in a report on Friday, May 8th. Mizuho set a $20.00 target price on Vital Farms in a report on Monday, May 4th. TD Cowen lowered Vital Farms from a “buy” rating to a “hold” rating and reduced their target price for the company from $25.00 to $16.00 in a report on Wednesday, April 8th. Finally, Wall Street Zen lowered Vital Farms from a “hold” rating to a “strong sell” rating in a report on Saturday, May 9th. Five analysts have rated the stock with a Buy rating, nine have assigned a Hold rating and one has given a Sell rating to the company’s stock. According to MarketBeat, Vital Farms has a consensus rating of “Hold” and a consensus target price of $27.33.
Read Our Latest Stock Analysis on VITL
Vital Farms Company Profile
Vital Farms, traded on the NASDAQ under the symbol VITL, is a U.S.-based food company specializing in pasture-raised egg and dairy products. The company partners with a network of family farms across the United States to produce eggs, butter and related items under a certified humane, pasture-centric farming model. Vital Farms’ supply chain emphasizes animal welfare, environmental stewardship and transparent sourcing, appealing to consumers seeking ethically produced, high-quality ingredients.
Founded in 2007 and headquartered in Austin, Texas, Vital Farms began by marketing pasture-raised eggs to health- and ethically minded shoppers.
Featured Stories
- Five stocks we like better than Vital Farms
- SpaceX IPO: Opportunity? Or the Ultimate Hype Trade?
- CAVA Group’s Stock Looks Delicious After Strong Earnings
- Lowe’s Finds Support at $215 After Q1 Earnings Sell-Off
- Deere Beats Q2 Estimates, But Ag Weakness Weighs on Outlook
Receive News & Ratings for Vital Farms Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Vital Farms and related companies with MarketBeat.com's FREE daily email newsletter.
